Streetbeat News

Analyst Ratings

NCLH

Stifel analyst Steven Wieczynski maintains a Buy rating on Norwegian Cruise Line (NYSE:NCLH) and raises the price target from $27 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:58 am

DIN

Truist Securities has downgraded Dine Brands Global from Buy to Hold and reduced its price target from $66 to $37.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:56 am

CVI

DHT

NAT

Analysts have provided their latest ratings on three high-dividend energy stocks: Nordic American Tankers (NAT), DHT Holdings (DHT), and CVR Energy (CVI). NAT was downgraded by Jefferies and had its price target cut by Evercore ISI. DHT received a price target increase from Stifel and an upgrade from Jefferies. CVI had its price target reduced by both JP Morgan and Mizuho.

Portfolio Pulse from Avi Kapoor

October 04, 2024 | 11:53 am

MURA

Raymond James has initiated coverage on Mural Oncology with a Strong Buy rating and set a price target of $18, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:52 am

GWRE

Oppenheimer analyst Ken Wong maintains an Outperform rating on Guidewire Software and raises the price target from $185 to $200.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:50 am

RPM

Morgan Stanley analyst Vincent Sinisi has maintained an Equal-Weight rating on RPM International (NYSE:RPM) while raising the price target from $107 to $125.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:48 am

WMB

Morgan Stanley has upgraded Williams Companies (NYSE:WMB) from Equal-Weight to Overweight and increased the price target from $52 to $58.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:46 am

LIVN

Goldman Sachs has initiated coverage on LivaNova with a Buy rating and set a price target of $65, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:43 am

IRTC

Goldman Sachs has initiated coverage on iRhythm Technologies with a Neutral rating and set a price target of $78.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:40 am

TNDM

Goldman Sachs has initiated coverage on Tandem Diabetes Care with a Neutral rating and set a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 11:38 am